Bagalanon, Janice Leslee .

HRN: 29-17-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2026
CO-AMOXICLAV 625MG (TAB)
06/20/2026
06/27/2026
ORAL
625 Mg
BID
PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: